Overview

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to compare the safety and efficacy of multiple formulations of BLI1100 to a control group and placebo in treating patients with moderate-severe acne vulgaris.
Phase:
Phase 2
Details
Lead Sponsor:
Braintree Laboratories